Just 13 months ago, Ana Ward was negotiating the sale of a division of biotech company Ambion Inc. while creating the start-up company Asuragen Inc. from another Ambion division. For added excitement, while she was in the midst of the sale and spin-off, she also was finishing a master’s degree in business administration at the University of Texas at Austin.
Ward — Ambion’s former GC — always seeks the next challenge, from serving as general counsel for a startup, earning multiple advanced degrees to learning to play the piano.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
